Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin

IUBMB Life

Volumn 63, Issue 6, 2011, Pages 446-451

  Fanali, Gabriella ^a,c   Cao, Yu ^a,b   Ascenzi, Paolo ^b   Trezza, Viviana ^b   Rubino, Tiziana ^a   Parolaro, Daniela ^a   Fasano, Mauro ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b ROMA TRE UNIVERSITY   (Italy)

^c Department of Structural and Functional Biology ^*  (Italy)

Author keywords

9 tetrahydrocannabinol binding; conformational transition(s); diazepam binding; human serum albumin; pharmacokinetics; poly drug use

Indexed keywords

DELTA9(11) TETRAHYDROCANNABINOL; DIAZEPAM; HEME; HUMAN SERUM ALBUMIN;

ALLOSTERISM; ARTICLE; BINDING AFFINITY; BINDING SITE; CONFORMATIONAL TRANSITION; DISSOCIATION CONSTANT; DRUG DELIVERY SYSTEM; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG USE; ENDOCYTOSIS; PROTEIN CONFORMATION; SIMULATION;

ANALGESICS, NON-NARCOTIC; ANTI-ANXIETY AGENTS; BINDING SITES; DIAZEPAM; HUMANS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SERUM ALBUMIN; TETRAHYDROCANNABINOL;

CANNABIS;

EID: 79959613725     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.466     Document Type: Article

References (34)

1. SAMHSA. Substance Abuse and Mental Health Service Administration. Office of Applied Studies. Results from the 2007 National Survey on Drug Use and Health: National Findings Office of Applied Studies (NSDUH Series H-34. DHHS Publication No. SMA 08-4343). Rockville, MD.
2. Naderi, N., Haghparast, A., Saber-Tehrani, A., Rezaii, N., Alizadeh, A. M., Khani, A., and, Motamedi, F., (2008) Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice. Pharmacol. Biochem. Behav. 89, 64-75.
3. Lile, J. A., Kelly, T. H., and, Hays, L. R., (2010) The reinforcing, self-reported performance and physiological effects of Delta9- tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in cannabis users. Behav. Pharmacol. 21, 29-38.
4. Sudlow, G., Birkett, D. J., and, Wade, D. N., (1975) The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 11, 824-832.
5. Peters, T. Jr., (1996) All about Albumin: Biochemistry, Genetics and Medical Applications. Academic Press, Orlando, FL.
6. Ghuman, J., Zunszain, P. A., Petitpas, I., Bhattacharya, A. A., Otagiri, M., and, Curry, S., (2005) Structural basis of the drug-binding specificity of human serum albumin. J. Mol. Biol. 353, 38-52. (Pubitemid 41338838)
7. Ascenzi, P., Bocedi, A., Notari, S., Fanali, G., Fesce, R., and, Fasano, M., (2006) Allosteric modulation of drug binding to human serum albumin. Mini Rev. Med. Chem. 6, 483-489.
8. Ascenzi, P., and, Fasano, M., (2009) Serum heme-albumin: an allosteric protein. IUBMB Life 61, 1118-1122.
9. Ascenzi, P., and, Fasano, M., (2010) Allostery in a monomeric protein: the case of human serum heme-albumin. Biophys. Chem. 148, 16-22.
10. Fanali, G., Rampoldi, V., di Masi, A., Bolli, A., Lopiano, L., Ascenzi, P., and, Fasano, M., (2010) Binding of anti-Parkinson's disease drugs to human serum albumin is allosterically modulated. IUBMB Life 62, 371-376.
11. Sugio, S., Kashima, A., Mochizuki, S., Noda, M., and, Kobayashi, K., (1999) Crystal structure of human serum albumin at 2.5 Å resolution. Protein Eng. 12, 439-446. (Pubitemid 29322441)
12. Zunszain, P. A., Ghuman, J., Komatsu, T., Tsuchida, E., and, Curry, S., (2003) Crystal structural analysis of human serum albumin complexed with hemin and fatty acid. BMC Struct. Biol. 3, 6.
13. Petitpas, I., Grüne, T., Bhattacharya, A. A., and, Curry, S., (2001) Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J. Mol. Biol. 314, 955-960. (Pubitemid 34073060)
14. Chuang, V. T. G., and, Otagiri, M., (2002) How do fatty acids cause allosteric binding of drugs to human serum albumin? Pharm. Res. 19, 1458-1464. (Pubitemid 35266549)
15. Hamilton, J. A., (2004) Fatty acid interactions with proteins: what X-ray crystal and NMR solution structures tell us. Prog. Lipid. Res. 43, 177-199. (Pubitemid 38299192)
16. Fasano, M., Fanali, G., Leboffe, L., and, Ascenzi, P., (2007) Heme binding to albuminoid proteins is the result of recent evolution. IUBMB Life 59, 436-440. (Pubitemid 47123995)
17. Chen, R. F., (1967) Removal of fatty acids from serum albumin by charcoal treatment. J. Biol. Chem. 242, 173-181.
18. Sogami, M., and, Foster, J. F., (1968) Isomerization reactions of charcoal-defatted bovine plasma albumin. The N-F transition and acid expansion. Biochemistry 7, 2172-2182.
19. Cabrera-Crespo, J., Goncalves, V. M., Martins, E. A., Grellet, S., Lopes, A. P., et al. (2000) Albumin purification from human placenta. Biotechnol. Appl. Biochem. 31, 101-106. (Pubitemid 30197872)
20. Boffi, A., Das, T. K., Della Longa, S., Spagnuolo, C., and, Rousseau, D. L., (1999) Pentacoordinate hemin derivatives in sodium dodecyl sulfate micelles: model systems for the assignment of the fifth ligand in ferric heme proteins. Biophys. J. 77, 1143-1149. (Pubitemid 29362485)
21. Bocedi, A., Notari, S., Menegatti, E., Fanali, G., Fasano, M., and, Ascenzi, P., (2005) Allosteric modulation of anti-HIV drug and ferric heme binding to human serum albumin. FEBS J. 272, 6287-6296. (Pubitemid 41815617)
22. Goodsell, D. S., and, Olson, A. J., (1990) Automated docking of substrates to proteins by simulated annealing. Proteins 8, 195-202. (Pubitemid 20363304)
23. Goodsell, D. S., Morris, G. M., and, Olson, A. J., (1998) Automated docking of flexible ligands: Applications of autodock. J. Mol. Recogn. 9, 1-5.
24. Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., and, Olson, A. J., (1998) Automated Docking Using a Lamarckian Genetic Algorithm and Empirical Binding Free Energy Function. J. Comput. Chem. 19, 1639-1662. (Pubitemid 128590223)
25. Schuettelkopf, A. W., and, van Aalten, D. M., (2004) PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D Biol. Crystallogr. 60, 1355-1363. (Pubitemid 41079731)
26. Cooper, Z. D., and, Haney, M., (2009) Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts. Drug Alcohol Depend. 103, 107-113.
27. Bocedi, A., Notari, S., Narciso, P., Bolli, A., Fasano, M., and, Ascenzi, P., (2004) Binding of anti-HIV drugs to human serum albumin. IUBMB Life 56, 609-614. (Pubitemid 40385357)
28. Gjerde, H., Mordal, J., Christophersen, A. S., Bramness, J. G., and, Mørland, J., (2010) Comparison of drug concentrations in blood and oral fluid collected with the Intercept sampling device. J. Anal. Toxicol. 34, 204-209.
29. Padgett, C. L., and, Slesinger, P. A., (2010) GABAB receptor coupling to G-proteins and ion channels. Adv. Pharmacol. 58, 123-147.
30. Fanali, G., Fesce, R., Agrati, C., Ascenzi, P., and, Fasano, M., (2005) Allosteric modulation of myristate and Mn(III)heme binding to human serum albumin. Optical and NMR spectroscopy characterization. FEBS J. 272, 4672-4683. (Pubitemid 41366990)
31. Fanali, G., Bocedi, A., Ascenzi, P., and, Fasano, M., (2007) Modulation of heme and myristate binding to human serum albumin by anti-HIV drugs. An optical and NMR spectroscopic study. FEBS J. 274, 4491-4502. (Pubitemid 47301710)
32. Bolli, A., Marino, M., Rimbach, G., Fanali, G., Fasano, M., and, Ascenzi, P., (2010) Flavonoid binding to human serum albumin. Biochem. Biophys. Res. Commun. 398, 444-449.
33. Bhattacharya, A. A., Gruene, T., and, Curry, S., (2000) Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J. Mol. Biol. 303, 721-732.
34. Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., and, Ferrin, T. E., (2004) UCSF chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612.